Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state

Wangie Yu(Baylor College of Medicine), Yunyun Chen(The University of Texas MD Anderson Cancer Center), Nagireddy Putluri(Baylor College of Medicine), Abdullah A. Osman(The University of Texas MD Anderson Cancer Center), Cristian Coarfa(Baylor College of Medicine), Vasanta Putluri(Baylor College of Medicine), Abu Hena Mostafa Kamal(Baylor College of Medicine), Jennifer Asmussen(Baylor College of Medicine), Panagiotis Katsonis(Baylor College of Medicine), Jeffrey N. Myers(The University of Texas MD Anderson Cancer Center), Stephen Y. Lai(The University of Texas MD Anderson Cancer Center), Wuhao Lu(Baylor College of Medicine), Clifford Stephan(Texas A&M Health Science Center), Reid T. Powell(Texas A&M Health Science Center), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Heath D. Skinner(UPMC Hillman Cancer Center), Jawad Kazi(Baylor College of Medicine), Kazi Mokim Ahmed(Baylor College of Medicine), Linghao Hu(Texas A&M University), Addison Threet(Texas A&M University), Matthew D. Meyer(Rice University), James A. Bankson(The University of Texas MD Anderson Cancer Center), Tony Wang(Baylor College of Medicine), Jack Davis(Baylor College of Medicine), Kirby R. Parker(Baylor College of Medicine), Madison A. Harris(Baylor College of Medicine), Mokryun L. Baek(Baylor College of Medicine), Gloria V. Echeverria(Baylor College of Medicine), Xiaoli Qi(Baylor College of Medicine), Jin Wang(Baylor College of Medicine), Andy I. Frederick(Cornell University), Alex J. Walsh(Texas A&M University), Olivier Lichtarge(Baylor College of Medicine), Mitchell J. Frederick(Baylor College of Medicine), Vlad C. Sandulache(Michael E. DeBakey VA Medical Center)
British Journal of Cancer
April 3, 2023
Cited by 22Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis